Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Texas OTC storage reg

This article was originally published in The Tan Sheet

Executive Summary

Final proposed version of the Texas Department of Health's storage and handling requirements for OTC drugs to be voted on at the board's Oct. 15 meeting. As expected, the reg has been rewritten to incorporate "very minimum standards" for OTC wholesalers, TDH said. As originally drafted, the reg would have applied federal storage standards to OTCs. CHPA and CTFA had lobbied for less stringent standards at a public meeting earlier this year (1"The Tan Sheet" Feb. 22, p. 20). Once approved by TDH, the proposed rule will be published in the Texas Register. A final version could come into effect by March 2000

You may also be interested in...

Texas OTC Drug Storage Proposal "Unnecessary, Burdensome" - NDMA

The new storage and handling requirements for OTC drugs recently proposed in Texas are "unnecessary to protect the public health; unduly burdensome on wholesalers and manufacturers; and disruptive of the national uniformity of drug laws," the Nonprescription Drug Manufacturers Association asserts in Jan. 22 comments to the state's health department.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts